Form 144 notice: 14,828 common shares scheduled

OCUL filed a Form 144 notifying the planned sale of 14,828 common shares tied to restricted stock vesting under a registered plan.

Rhea-AI Filing Summary

OCUL filed a Form 144 notifying the planned sale of 14,828 common shares tied to restricted stock vesting under a registered plan. The shares are scheduled for 06/01/2026 and the filing appears on 06/03/2026 for NASDAQ trading.

The filing lists an aggregate dollar figure of $122,648.32 associated with the transaction and identifies the sale method as pursuant to a registered plan; additional proceeds treatment or holder details are not shown in the excerpt.

Key Figures

Form date: 06/03/2026 Shares to be sold: 14,828 shares Aggregate figure: $122,648.32 +2 more

5 metrics

Form date 06/03/2026 Filing appearance date

Shares to be sold 14,828 shares Scheduled sale tied to restricted stock vesting on 06/01/2026

Aggregate figure $122,648.32 Dollar amount listed in the filing tables

Transaction date 06/01/2026 Date of restricted stock vesting / sale event

Identifier value 218,960,358 Numeric identifier present in the excerpt

Key Terms

restricted stock vesting, registered plan, Form 144

3 terms

restricted stock vesting regulatory

"Restricted stock vesting under a registered plan"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

registered plan regulatory

"restricted stock vesting under a registered plan"

A registered plan is a savings or investment account that a government recognizes for special tax treatment and rules, such as limits on how much you can put in and conditions for withdrawals. For investors it matters because those rules change how much of your gains are taxed, how quickly your money can be accessed and what strategies make sense — like a labeled jar that gives tax breaks but comes with rules about when and how you can take the money out.

Form 144 regulatory

"Filer Information ... 144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does OCUL's Form 144 disclose?

The Form 144 discloses a planned sale of 14,828 common shares. It states the sale stems from restricted stock vesting under a registered plan, scheduled on 06/01/2026, with a listed aggregate figure of $122,648.32.

When are the OCUL shares scheduled to be sold?

The shares are scheduled for sale on 06/01/2026. The filing entry shows the vesting/sale date as 06/01/2026 and the Form 144 appears dated 06/03/2026 on NASDAQ.

How many shares and what dollar amount are listed in OCUL's filing?

The filing lists 14,828 shares and $122,648.32. The excerpt pairs the share count 14,828 with an aggregate figure of $122,648.32 in the Form 144 tables.

Why are these OCUL shares being sold under Rule 144?

The sale is tied to restricted stock vesting under a registered plan. The Form 144 entry explicitly states "restricted stock vesting under a registered plan" as the reason for the proposed sale on 06/01/2026.

Does the Form 144 excerpt show who receives the proceeds?

The excerpt lists the seller as "Issuer" but does not detail proceeds treatment. The table labels the counterparty as "Issuer"; the filing does not show additional proceeds allocation information in this excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 04:06 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002023884
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	OCULAR THERAPEUTIX, INC.
SEC File Number	001-36554
Address of Issuer	15 Crosby Drive Bedford MASSACHUSETTS 01730
Phone	(781) 357-4000
Name of Person for Whose Account the Securities are To Be Sold	NADIA K. WAHEED
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14828	122648.32	218960358	06/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2026	Restricted stock vesting under a registered plan	Issuer			14828	06/01/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	06/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Nadia Waheed
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)